Vimarsana
Biggest News Aggregation in the World

Page 2 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

The Patient Knows Best: PROs in RA Practice and Research - Vimarsana News

The Patient Knows Best: PROs in RA Practice and Research

Advanced systems for measuring patient-reported outcomes can help improve care of patients with rheumatoid arthritis and inform clinical research.

Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA - Vimarsana News

Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA

Patients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous tocilizumab treatment, without any new safety concerns, in an LTE study of two trials.

High Infection Risk in RA-Associated ILD - Vimarsana News

High Infection Risk in RA-Associated ILD

A prospective study found that 96% of patients with RA-ILD had at least one serious infection, which proved fatal in 65% of cases.

Bone Infections Increase After S aureus Bacteremia in RA - Vimarsana News

Bone Infections Increase After S aureus Bacteremia in RA

The use of orthopedic implants or tumor necrosis factor inhibitors doubled the risk for bone infections in patients with RA who had contracted S aureus bacteremia.

Tuberculosis Screening Gaps Persist in New DMARD Users - Vimarsana News

Tuberculosis Screening Gaps Persist in New DMARD Users

Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.